ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000223393.1	ABT-263 (navitoclax)	Cervical squamouscell carcinoma and endocervical adenocarcinoma	0.021805999	Sensitive
ENSG00000223393.1	ABT-263 (navitoclax)	Sarcoma	0.017319246	Sensitive